El Mundo on MSN
The revolution of the 'Ozempic' drugs and the challenges of a solution for almost everything: "We are facing massive use"
A review by researchers from the Cochrane publication focuses on the new 'superdrugs': questioning the rebound effect, ...
Medicare coverage will cut obesity-drug prices but open the door to millions of new patients.
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback